Skip to main content
TNXP
NASDAQ Life Sciences

Tonix Secures Medicare Part D Coverage for TONMYA, Expanding Access to 145M Lives

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$13.2
Mkt Cap
$199.738M
52W Low
$10.03
52W High
$69.97
52W Position info
32% above low
Off High info
81% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

TNXP sits 32% above its 52-week low of $10.03.

Summary

Tonix Pharmaceuticals has secured a Medicare Part D payer agreement for its fibromyalgia drug TONMYA, adding coverage for approximately 9 million beneficiaries effective January 1, 2027. This builds on prior commercial and Medicaid wins, bringing total covered lives to an expected 145 million—roughly 46% of U.S. covered lives—on that date. The company is also expanding its sales force by about 50 representatives to 150 total, with deployment planned by mid-Q3 2026. The news follows a series of positive coverage announcements and a recent $22.6 million capital raise, but the company still carries a going-concern warning and significant cash burn. The expanded coverage and sales force signal a serious commercial push for TONMYA, which could materially improve revenue trajectory if uptake meets expectations.

At the time of this announcement, TNXP was trading at $13.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $199.7M. The 52-week trading range was $10.03 to $69.97. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

TNXP - Latest Insights

TNXP
Nov 13, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.99
Real-time Price: $2.82 info
Change: -$0.170 (-6%) info
Market Cap: $54.797M info
TNXP
Nov 09, 2026, 8:25 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.00
Real-time Price: $2.82 info
Change: -$1.18 (-30%) info
Market Cap: $54.797M info
TNXP
Nov 09, 2026, 7:20 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.10
Real-time Price: $2.82 info
Change: -$1.28 (-31%) info
Market Cap: $54.797M info
TNXP
Nov 09, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.35
Real-time Price: $2.82 info
Change: -$1.53 (-35%) info
Market Cap: $54.797M info
TNXP
Oct 27, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $5.36
Real-time Price: $2.82 info
Change: -$2.54 (-47%) info
Market Cap: $54.797M info